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Protein crystallization has been revolutionized by the intro-
duction of high-throughput technologies, which have led to a
speeding up of the process while simultaneously reducing the
amount of protein sample necessary. Nonetheless, the
chemistry dimension of protein crystallization has remained
relatively undeveloped. Most crystallization screens are based
on the same set of precipitants. To address this shortcoming,
the development of new protein precipitants based on poly-
-glutamic acid (PGA) polymers with different molecular-
weight ranges is reported here: PGA-LM (low molecular
weight) of  400 kDa and PGA-HM (high molecular weight)
of >1000 kDa. It is also demonstrated that protein precipitants
can be expanded further to polymers with much higher
molecular weight than those that are currently in use.
Furthermore, the modiﬁcation of PGA-like polymers by
covalent attachments of glucosamine substantially improved
their solubility without affecting their crystallization proper-
ties. Some preliminary PGA-based screens are presented here.
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1. Introduction
The ﬁeld of protein crystallization has undergone an extra-
ordinary transformation in the last decade. High-throughput
(HT) screening technologies have enabled more rapid deter-
mination of protein structures (often in a matter of hours) and
reduced the consumption of biological material. Other
innovations include the development and adaptation of
protein-handling robots and liquid dispensers. As a result, the
crystallization process can now be almost entirely automatic,
while the single trial (‘condition’) volume of the protein has
been reduced from the typical manual 1 ml setup to  50–
150 nl. The efﬁciency of protein crystallization can be
increased even further by the application of automated
microdiffusion devices (Hansen et al., 2002; Chen et al., 2007).
Liquid-handling robots are also taking over the preparation of
screen solutions. These advances have been accompanied by
progress in other crystallization-related consumables, espe-
cially in the area of crystallization plates; more than 30 formats
of these are currently available. Furthermore, the single
precipitant volume in the sitting drop-like setup may be
minimized to  1.2 ml, while also accelerating the crystal-
growth process (Korczyn ´ska et al., 2007). Although dialysis-
based setups have not been satisfactorily adapted to HT
technologies, counter-diffusion capillary-based devices have
already been designed and implemented (Garcia-Ruı ´z et al.,
2002; Garcia-Ruı ´z, 2003; Ng et al., 2003). Traditional seeding
techniques have also been adapted to HT formats, including
both protein-derived and artiﬁcial nucleants (see, for example,
Bergfors, 2003; D’Arcy et al., 2007; Chayen et al., 2006).In contrast to these innovations, progress in the develop-
ment of chemical tools for crystal growth has lagged behind. It
is likely that there are more than 100 screens available today
(a summary of the most common 92 formulations can be found
at http://xray.bmc.uu.se/markh/php/xtalscreens.php?func=
lookup&screen_name=Expand+List; courtesy of Mark Harris,
Uppsala), but most contain similar types of salts, polymers
(e.g. PEGs, Jeffamines) and additives, albeit at different ratios,
pHs and concentrations. One notable exception is the recent
formulation of the Silver Bullets screen, which utilizes a
plethora of new (or previously reported) additives. These have
been shown to be useful in the formation of crucial crystal
contacts or enhancing protein conformations (McPherson &
Cudney, 2006; Larson et al., 2007).
An alternative to polymer-based precipitants are organic
salts (e.g. sodium malonate, oxalate, formate; McPherson,
2001). Novel chemistry in protein crystallization also includes
lipids in the form of lipidic cubic phases (Landau & Rosen-
busch, 1996) for membrane proteins. However, these devel-
opments only underline the lack of new polymer-based
precipitants. The only recently reported polymers that have
had a signiﬁcant impact on the efﬁciency of crystallization
screens are the monomethyl PEGs, which appeared 14 y ago
(Brzozowski & Tolley, 1994), Jeffamine M-600, poly-
ethyleneimine (Cudney et al., 1994), polyacrylic acid, poly-
vinylpyrolidone, polypropylene glycol, polyvinyl alcohol, PEG
dimethyl ether (Patel et al., 1995) and pentaerythritol
propoxylate (Gulick et al., 2002).
In the face of this discrepancy, we embarked on a project to
design, synthesize, test and implement new varieties of poly-
mers for protein crystallization. Our primary goal was to
develop new precipitants/media for the crystallization of
membrane proteins. Owing to the extremely challenging
character of these proteins this area suffers most from the
shortage of chemical tools, although new chemical media for
globular proteins would also be desirable. Here, we report the
application of poly--glutamic acid (PGA) based polymers
(Fig. 1) to the crystallization of globular and membrane
proteins. This is also the ﬁrst report of the successful use of
polymers with a molecular weight well over 1000 kDa in the
process of protein crystallization. Because most conventional
polymeric precipitants are limited to a maximum of 20 kDa
molecular weight (e.g. PEG 20K), our results open up new
possibilities for macromolecular crystallization. Although the
application of high-molecular-weight polymers ( 400–
700 kDa) has previously been
reported for low- and high-
viscosity carboxymethylcellulose
(CMC; Patel et al., 1995), there
are no screens based on CMC as
the main precipitant.
Interest in PGA-like polymers
stemmed from our search for
gel-forming hydrophilic macro-
molecules with high swelling
properties. It was vital that they
should also be nontoxic, nonde-
naturing and readily accessible for research. Trials with several
different polymers [e.g. poly(l-lactide), poly(ether amide),
poly(butylene terephthalate) and poly(hydroxybutyrate)]
indicated the PGA was promising not only for gel formation
but also for protein crystallization.
PGA is a naturally occurring biopolymer synthesized from
l-glutamic acid by Bacillus subtilis var. natto (Hara & Ueda,
1982). B. subtilis is the preferred source of this macromolecule
as its chemical synthesis is not very efﬁcient (Sanda et al.,
2001). PGA is a main component of natto (a Japanese health
food) and its polyanionic and nontoxic properties also make it
an important and widely used component in food additives,
cosmetics, water treatments and natural biocides. It is
commercially available in two different molecular-weight
ranges: low-molecular-weight PGA (PGA-LM) of  200–
400 kDa and high-molecular-weight PGA (PGA-HM) with an
average range of  1000–2000 kDa. As the natural PGAs are
linear structures, we have also derivatized these polymers to
achieve even greater swelling properties and more branched
versions of them.
Here, we describe the application of PGA and its deriva-
tives in protein crystallization and propose a strategy for
crystallization screens based on this polymer.
2. Material and methods
2.1. Preparation of the PGA for the template screen
PGAwas purchased from Vedan Enterprise Corp., Taiwan.
PGA-LM was poly--PGA (Na
+salt form)cosmetic grade LM
[OD400 maximum 0.07 for 4%(w/v) aqueous solution] with an
average MW of  200–400 kDa, with a particle size of 100%
through 100 mesh. PGA-HM was poly--PGA (Na
+ salt form)
cosmetic grade HM [OD400 maximum 0.07 for 4%(w/v)
aqueous solution] with an average MW of >1000 kDa, with a
particle size of 100% through 100 mesh. PGA-LM stock
solutions in deionized water were 20–50%(w/v), while PGA-
HM stocks were 5–20%(w/v). All other chemicals were from
Sigma–Aldrich.
2.2. Preparation and synthesis of PGA–glucose conjugates
Glucose units in the form of glucosamine were incorporated
into both types of PGA via amide coupling (see Fig. 1). The
amide-coupling reaction was carried out in a two-phase system
(Ho et al., 1995) using EDC [N-(3-dimethylaminopropyl)-N0-
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Figure 1
Synthesis scheme of poly--glutamate–glucosamine conjugates via amide coupling in a two-phase system
using EDC/DMAP (Ho et al., 1995). The molecule on the left shows the original unmodiﬁed PGA.ethyl carbodiimide hydrochloride] and DAMP [4-(dimethyl-
amino)pyridine]. In the case of PGA-LM, 1.51 g of the
biopolymer, 1.08 g (5 mmol) glucosamine hydrochloride and
1.05 g (5 mmol) EDC were loaded into a 250 ml round-bottom
ﬂask with 100 ml deionized water. 4-(Dimethylamino)pyridine
(153 mg, 1.25 mmol) and triethylamine (0.7 ml, 5 mmol) were
dissolved in 50 ml dichloromethane and then added to the
reaction ﬂask. The mixture was stirred for 24 h. The aqueous
phase was transferred to a separation funnel and washed with
50 ml dichloromethane. The aqueous solution was further
dialysed against 0.05 M HCl and subsequently against de-
ionized water. The ﬁnal product was obtained through vacuum
drying as a white solid with a 62% (1.6 g) yield. The ratio
between the glutamic acid unit and conjugated glucose was
estimated by
1H NMR (see Fig. 2):
1H NMR (400 MHz, D2O,
p.p.m.), 4.18 (glutamic  proton, 1H, m), 3.8–2.9 (glucose
protons, 7H, m), 2.20 (glutamic  protons, 2H, m), 1.98–1.65
(glutamic  protons, 2H, m);
13C NMR (100 MHz, D2O,
p.p.m.), 175–174 (carbonyl C atoms), 91.2 (glucose C6), 75.9,
74.1, 71.8, 69.8 (glucose C3–5), 61.8 (glucose C1), 55.5 (glucose
C2), 52.1 (glutamic  carbon), 31.5 (glutamic  carbon), 26.5
(glutamic  carbon).
2.3. Test proteins
Lysozyme (Sigma), Trichoderma reesei xylanase (Hampton
Research) and Streptomyces rubiginosus glucose isomerase
(Hampton Research) were used as test proteins. Prior to use
with the PGA solutions, the crystallizability of these proteins
was optimized (as described in Korczyn ´ska et al., 2007) on
24-well Linbro tissue plates with 1 ml well solution and 1 ml
protein + 1 ml precipitant solution and on 96-well Greiner
CrystalQuick plates with standard drops of 150 nl protein +
150 nl precipitant and 100 ml reservoir solution. 96-well setups
were performed with Mosquito (TTP Labtech, UK). The
conditions for the three test proteins were as follows: lyso-
zyme, 30 mg ml
 1 protein in 50 mM sodium acetate buffer pH
5.0, 0.1 M sodium acetate buffer pH 4.5, 1.0 M NaCl; xylanase,
35 mg ml
 1 protein in 50 mM Tris–HCl pH 7.5, condition A
[0.1 M Tris–HCl pH 8.5, 0.2 M LiCl, 20%(w/v) PEG 4000];
glucose isomerase at 38 mg ml
 1 in 50 mM Tris–HCl pH 7.5,
condition A [0.1 M Tris–HCl pH 7.0, 0.2 M MgCl2, 20%(v/v)
PEG 400], condition B [0.1 M Tris–HCl pH 7.0, 0.2 M MgCl2,
23%(v/v) MPD]. All crystallizations were carried out at room
temperature (292   0.5 K).
In addition to the test proteins, the PGA solutions and
screens were tested on ten previously uncrystallized proteins,
including two membrane proteins, from ongoing projects at
the York Structural Biology Laboratory (YSBL) and the
Department of Biology, University of York.
2.4. Preparation of the screens
Detailed compositions of the screens is provided in
Tables 1–5. All screens were made up to 90% of their ﬁnal
volume, allowing a further top-up of the remaining 10%
volume with 1 M stock buffer at the desired pH, similar to the
strategy used in CSS screens (Brzozowski & Walton, 2001).
3. Results and discussion
3.1. Preliminary evaluation of PGAs in protein crystallization
Initial solubility trials of the PGAs showed that the stock
solutions of both biopolymers could be prepared at concen-
trations that were high enough for
protein-crystallization trials. As
expected, it was possible to make
a 50%(w/v) stock of PGA-LM,
but the PGA-HM stock could
only be dissolved to 10–20%(w/v).
However, for practical reasons
the PGA-LM stocks were
frequently used at 20–30%(w/v).
The viscosity of PGA solutions
[e.g. 150 mPa s for 4%(w/v) PGA-
HM and 50 mPa s for 4%(w/v)
PGA-LM (both in water; Vedan
Technical Data); for comparison,
50%(w/v) PEG 6K has a viscosity
of 100 mPa s] allowed manual
dispensing. Their compatibility
with large-volume liquid-handling
robots employed for screen
making was not tested here but
should be feasible.
It has to be stressed that the
three test proteins (lysozyme,
glucose isomerase and xylanase)
are all easily crystallizable. They
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Figure 2
1H NMR spectra of poly--glutamic acid (a) and its synthesized glucosamine conjugate (b). The ratio of the
incorporated carbohydrate is estimated by integration of the glutamic and glucose protons. In this
particular case, the ratio of the glucosamine-conjugated and non-glucosamine-conjugated glutamic
segments is about 1:1.were used here not to assess the increased (if any) crystal-
lization efﬁciency of the PGAs but to check whether PGA-
based polymers were even feasible to use, i.e. that they would
not inhibit crystal growth. As the real usefulness of the PGAs
can only be established if they work for real (not typical test)
proteins, the PGAs were partially validated here on ten
proteins from ongoing projects within the YSBL, including
two bona ﬁde membrane proteins.
At ﬁrst, both PGAs were used as additives [0.7–2%(w/v)] in
the test conditions established for the three test proteins. As
they did not visibly interfere with (or inhibit) the crystal
growth of the test proteins, they were tested as the main
precipitants at 1–20%(w/v) for PGA-LM and 0.5–5%(w/v) for
PGA-HM over a range of pH values from 4.5 to 7.8 with and
without different salts (average salt concentration: 0.2 M). A
plethora of crystals from all test proteins were obtained over
the whole range of PGA concentrations (with or without salts;
Figs. 3a–3c). As the result of this preliminary screening, the
ﬁrst simple template PGA-based screen was formulated
(Table 1). Practically all conditions (A–H)with all salts yielded
test crystals over the three selected pH values, with an obvious
preference for pH 4.5 in the case of lysozyme and pH 7.8 for
glucose isomerase and xylanase.
It should be emphasized here that PGAs are polyanionic
polymers and have substantial chelating properties which, for
example, explain their use in water treatment. Therefore, the
role of any inorganic/organic salts used in conjunction with the
PGAs may be quite different from that they may have in
classical (e.g. PEG-based) screens. However, as the salts used
in the template PGA screen are at high molar concentrations,
they are likely to still exhibit protein-crystallization activities,
whereas at millimolar levels their cations would be effectively
scavenged from the solution by the PGA.
3.2. Carbohydrate–PGA-based crystallization screening
As the template PGA screen was very effective in crystal-
lization of the test proteins, it was modiﬁed further to enhance
its swelling properties by adding pectin and gum arabic,
respectively. Both of these carbohydrates have been found to
be useful additives for slowing down crystal growth and
minimizing nucleation (AMB, unpublished results). Test
crystals were obtained over a wide range of pectin/gum arabic
concentrations (Figs. 3d–3f), but the best results (crystals with
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Figure 3
Examples of lysozyme crystal growth from PGA-LM. (a)1 % ( w/v) PGA-LM, 0.2 M NaCl pH 4.5. (b)A s( a) but with 5%(w/v) PGA-LM. (c)A s( a) but
with 10%(w/v) PGA-LM; crystals grow here as easily as in (a) but frequently intergrow into each other and cluster. (d)A s( a) but with 1%(w/v) pectin.
(e)A s( a) but with 10%(w/v) pectin; a signiﬁcant slowing of crystal growth can be observed with ‘step/spiral-like’ individual crystal faces. (f)A s( a) but
with 10%(w/v) gum arabic; some three-dimensional in-gel-like distribution of the crystal can be observed here despite the relatively low viscosity of the
solution.
Table 1
The template PGA screen.
12 3 45 6
5%(w/v) PGA-LM 5%(w/v) PGA-HM
0.1 M NaOAc
pH 4.5
0.1 M MES
pH 6.5
0.1 M Tris
pH 7.8
0.1 M NaOAc
pH 4.5
0.1 M MES
pH 6.5
0.1 M Tris
pH 7.8
A 0.2 M MgCl2
B 0.2 M (NH4)2SO4
C 0.2 M Li2SO4
D 0.6 M Na2SO4
E 0.6 M sodium formate
F 0.2 M zinc acetate
G 0.2 M KSCN
H 0.2 M KBrwell shaped morphology) were obtained for 1%(w/v) pectin
and 5%(w/v) gum arabic. Interestingly, some of the PGA/gum
arabic solutions resulted in suspension-like crystal growth in
the whole volume of the drop that is more typical of gel-like
sedimentation-free crystallizations (Fig. 3f; see, for example,
Garcia-Ruı ´z et al., 2001; Willaert et al., 2005). However, the
‘working’ viscosities of the PGA/gum arabic media used in
these crystallization remained very similar to those of the
PGA solutions without the carbohydrates. In some cases
(Fig. 3e), slowing down the crystal growth produced crystals
with visible spiral/step-like growth of crystal faces, which
suggests that this could also be interesting for crystal-growth
studies.
The template PGA screen was modiﬁed further to incor-
porate the best results obtained with the addition of the
carbohydrates and 1%(w/v) pectin and 5%(w/v) gum arabic
were added to all conditions. The resulting carbohydrate–
PGA screen was formulated and tested. Both template PGA
and carbohydrate–PGA screens were set up at three different
pH values: 4.5 (0.1 M sodium acetate), 6.5 (0.1 M cacodylate)
and 7.8 (0.1 M Tris–HCl). The reﬁned conditions are
summarized in Table 2 in terms of the most effective crystal-
lization of the test proteins. The addition of the carbohydrates
in the carbohydrate–PGA screen slowed (by  1–3 d) crystal
growth of the test proteins, as expected. However, application
of the carbohydrate–PGA screen to the ongoing YSBL
projects was not visibly beneﬁcial. Therefore, pectin and gum
arabic were not used further in reﬁnement of the PGA-based
screens, although their exploitation may still be helpful for
some proteins. They should not be disregarded in further
applications and developments, especially in the optimization
of crystal growth.
3.3. Covalent modification of the PGAs
As the general applicability of the PGAs in the crystal-
lization process had been established, we also explored the
branching of these biopolymers, this time not by the addition
of other chemical components but by covalent modiﬁcation.
Several glucosamine derivatives of both PGAs were synthe-
sized using amide-coupling reactions. The resulting glucos-
amine PGAs were obtained (Fig. 1) with different glutamic
acid:glucosamine molar ratios for both PGA-LM and PGA-
HM. Subsequently, we focused on glucosamine PGA polymers
with an average 2:1 glutamic acid:glucosamine molar ratio,
which was the most straightforward to control during the
synthesis, puriﬁcation and characterization of the resulting
modiﬁed polymer. Other carbohydrates were considered for
further modiﬁcations but their organic synthesis proved not to
be cost-effective for large-scale crystallization trials.
As expected, the solubility of the glucosamine-modiﬁed
branched PGAs increased substantially. From a solubility
point of view, the conjugation with glucosamine was un-
necessary in the case of PGA-LM as 20–50%(w/v) stock
solutions were easily obtained. However, modiﬁcation of the
PGA-HM to glucosamine-PGA-HM signiﬁcantly elevated its
solubility and allowed the preparation of 40%(w/v) stock
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Table 2
The 96-condition carbohydrate–PGA screen.
1 2 34 5 67 8 91 0 1 11 2
5%(w/v) PGA-LM 5%(w/v) PGA-HM 5%(w/v) PGA-LM 5%(w/v) PGA-HM
0.1 M NaOAc
pH 4.5
0.1 M MES
pH 6.5
0.1 M Tris
pH 7.8
0.1 M NaOAc
pH 4.5
0.1 M MES
pH 6.5
0.1 M Tris
pH 7.8
0.1 M NaOAc
pH 4.5
0.1 M MES
pH 6.5
0.1 M Tris
pH 7.8
0.1 M NaOAc
pH 4.5
0.1 M MES
pH 6.5
0.1 M Tris
pH 7.8
A 0.2 M MgCl2 +1 % ( w/v) pectin 0.2 M MgCl2 +5 % ( w/v) gum arabic
B 0.2 M (NH4)2SO4 +1 % ( w/v) pectin 0.2 M (NH4)2SO4 +5 % ( w/v) gum arabic
C 0.2 M Li2SO4 +1 % ( w/v) pectin 0.2 M Li2SO4 +5 % ( w/v) gum arabic
D 0.6 M Na2SO4 +1 % ( w/v) pectin 0.6 M Na2SO4 +5 % ( w/v) gum arabic
E 0.6 M sodium formate + 1%(w/v) pectin 0.6 M sodium formate + 5%(w/v) gum arabic
F 0.2 M zinc acetate + 1%(w/v) pectin 0.2 M zinc acetate + 5%(w/v) gum arabic
G 0.2 M KSCN + 1%(w/v) pectin 0.2 M KSCN + 5%(w/v) gum arabic
H 0.2 M KBr + 1%(w/v) pectin 0.2 M KBr + 5%(w/v) gum arabic
Table 3
The 16 glucosamine-PGA conditions.
Columns 1 and 2 contain the same salts at identical concentrations. Rows E–H
in columns 1 and 2 also contain 10%(w/v) PEG 2K MME.
12
15%(w/v) glucosamine-PGA-LM 15%(w/v) glucosamine-PGA-HM
A 0.2 M (NH4)2SO4
B 0.2 M sodium formate
C 0.2 M MgCl2
D 0.2 M KBr
E 0.2 M (NH4)2SO4, 10%(w/v) PEG 2K MME
F 0.2 M sodium formate, 10%(w/v) PEG 2K MME
G 0.2 M MgCl2, 10%(w/v) PEG 2K MME
H 0.2 M KBr, 10%(w/v) PEG 2K MME
Table 4
16 conditions that were found useful in combination of glucosamine-PGA
with regular PEGs.
PEG 3350 was at 25%(w/v) and PEG 400 at 35%(w/v).
12
5%(w/v) glucosamine-PGA-LM 5%(w/v) glucosamine-PGA-HM
A PEG 3350 PEG 3350
B PEG 400 PEG 400
C PEG 3350, 0.2 M MgCl2 PEG 3350, 0.2 M MgCl2
D PEG 400, 0.2 M MgCl2 PEG 400, 0.2 M MgCl2
E PEG 3350, 10% Tacsimate PEG 3350, 10% Tacsimate
F PEG 400, 10% Tacsimate PEG 400, 10% Tacsimate
G PEG 3350, 0.2 M KSCN PEG 3350, 0.2 M KSCN
H PEG 400, 0.2 M KSCN PEG 400, 0.2 M KSCNsolutions [in comparison with 10–20%(w/v) for unmodiﬁed
PGA-HM]. Although both glucosamine-PGA-LM and
glucosamine-PGA-HM were also effective in the crystal-
lization of the test proteins in ranges very similar to those
achieved for the non-modiﬁed PGAs (Table 3 shows one such
screen), their widespread applications were limited owing to
the cost of their synthesis. Nonetheless, they were efﬁciently
and economically used in the YSBL with the mplate (Korc-
zyn ´ska et al., 2007), which consumes a maximum of 1.2 ml
reservoir solution per condition. As a result, glucosamine-
PGA-LM and glucosamine-PGA-HM were tested further, not
as the main precipitants, but as high-molecular-weight addi-
tives to other PEGs (Table 4).
3.4. Formulation of the final PGA-based screen
As combination of glucosamine-PGA-LM/glucosamine-
PGA-HM with PEGs was also highly effective in obtaining
test crystals, the combination of nonmodiﬁed PGAs and PEG
was also explored, resulting in the formulation of the ‘ﬁnal’
PGA-based (PGA screen) crystallization matrix (Table 5). For
practical reasons (e.g. high viscosity) and as a result of a very
similar efﬁciency in crystallization properties, we decided to
base the PGA screen entirely around PGA-LM rather than
PGA-HM. This does not exclude PGA-HM (or glucosamine-
PGAs) from future possible applications; instead, this decision
acknowledges that PGA-LM can act very effectively for all
PGA biopolymers in the initial crystallization screening. The
ﬁnal PGA screen combines several features of the PGA
polymers that have been identiﬁed here as being useful for
protein crystallization. These include (i) the capability of PGA
to work as a stand-alone new protein precipitant (columns 1–2
in Table 5), (ii) its easy mixing properties with other PEGs
(columns 3–4) and (iii) its stability in the presence of salts and
other additives (columns 5–12). It is likely that the efﬁciency
of the combination of PGA and PEGs derives from the co-
existence of these two very different (especially in terms of
molecular size) polymer-based crystallization media instead of
their cumulative/additive effect. The large physico-chemical
differences between these two polymers, in combination with
their similar effectiveness in inducing protein crystallization,
make them attractive candidates for further experimentations
with screens (e.g. different molar ratios, different additives,
salts etc.). Surprisingly, the crystallization efﬁciency, under-
stood here simply as the minimum polymer concentration
yielding crystals, was not very narrow in case of PGA-LM (or
any other of the PGAs); crystals of the same test protein were
obtained over a wide PGA concentration [e.g.  1–20%(w/v)].
Therefore, PGA-LM is used in columns 1–6 of the PGA screen
at two very different concentrations to maximize the chance of
nucleation and crystal growth.
3.5. Implications of PGAs for protein crystallization
We want to stress here that the ultimate and most stringent
assessment of PGA in protein crystallization (for example via
PGA-containing screens) can only be carried out on
previously uncrystallized proteins. As previously stated, the
test proteins employed here have mostly served as a preli-
minary assessment of the crystallization capabilities of the
PGAs rather than as the most reliable means for the formu-
lation of the PGA screen. As most of the YSBL-based
research is focused on well deﬁned targets, a genomics-type
range of new proteins was not available here for extensive
real-life scenario tests. Nonetheless, a PGA screen (as well as
other PGAs screens described here) was tested on ten
research papers
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Table 5
The ﬁnal 96-well PGA screen.
All PEG concentrations are given in %(w/v); glycerol, MPD and 1,2,6-hexanetriol (HXT) concentrations are given in %(v/v).
123 4 5 6
8% PGA-LM 16% PGA-LM 5% PGA-LM 15% PGA-LM 5% PGA-LM 15% PGA-LM
A 0.3 M KBr 0.3 M KBr 20% PEG 1K 20% PEG 1K 30% PEG 200 20% PEG 200
B 0.2 M MgCl2 0.2 M MgCl2 20% PEG 2K MME 20% PEG 2K MME 30% PEG 400 20% PEG 400
C 10% Tacsimate 10% Tacsimate 20% PEG 3350 20% PEG 3350 30% PEG 550 MME 20% PEG 550 MME
D 0.2 M Na formate 0.2 M Na formate 15% PEG 4K 15% PEG 4K 30% PEG 750 MME 20% PEG 750 MME
E 0.4 M NH4 formate 0.4 M NH4 formate 20% PEG 5K MME 20% PEG 5K MME 30% PEG 600 20% PEG 600
F 0.2 M KSCN 0.2 M KSCN 15% PEG 6K 15% PEG 6K 30% MPD 20% MPD
G 0.2 M proline 0.2 M proline 12% PEG 8K 12% PEG 8K 20% HXT 20% HXT
H 0.2 M arginine 0.2 M arginine 10% PEG 20K 10% PEG 20K 20% glycerol 20% glycerol
78 91 0 1 1 1 2
10% PGA-LM,
10% Tacsimate
10% PGA-LM,
10% Tacsimate
10% PGA-LM,
0.3 M KBr
10% PGA-LM,
0.3 M KBr
10% PGA-LM,
0.2 M KSCN
10% PGA-LM,
0.2 M KSCN
A 20% PEG 1K 30% PEG 200 20% PEG 1K 30% PEG 200 20% PEG 1K 30% PEG 200
B 20% PEG 2K MME 30% PEG 400 20% PEG 2K MME 30% PEG 400 20% PEG 2K MME 30% PEG 400
C 20% PEG 3350 30% PEG 550 MME 20% PEG 3350 30% PEG 550 MME 20% PEG 3350 30% PEG 550 MME
D 15% PEG 4K 30% PEG 750 MME 15% PEG 4K 30% PEG 750 MME 15% PEG 4K 30% PEG 750 MME
E 20% PEG 5K MME 30% PEG 600 20% PEG 5K MME 30% PEG 600 20% PEG 5K MME 30% PEG 600
F 15% PEG 6K 30% MPD 15% PEG 6K 30% MPD 15% PEG 6K 30% MPD
G 12% PEG 8K 20% HXT 12% PEG 8K 20% HXT 12% PEG 8K 20% HXT
H 10% PEG 20K 20% glycerol 10% PEG 20K 20% glycerol 10% PEG 20K 20% glycerolpreviously uncrystallized proteins from the YSBL including
two bona ﬁde membrane proteins. The results with the
membrane proteins were especially encouraging as  25% of
the conditions of the PGA screen yielded diffraction-quality
crystals (the crystallization details and structure solutions will
be described elsewhere). Consequently, we believe that the
PGA test data presented here strongly indicate the potential
usefulness of PGA in protein crystallization.
It is currently difﬁcult to assess the mechanism by which
PGAs induce protein crystallization. Their overall similarity to
PEGs (linearity, hydrophilic/solubility proﬁles) may suggest
the volume-exclusion mechanism proposed for PEGs
(McPherson, 1998). However, it can be also envisaged that the
polypeptide-like PGAs may have a much more dramatic
impact on the rearrangement of structured water shells
around proteins, a process that has been indicated as crucial
for favourable thermodynamics of protein crystallization
(Vekilov, 2007; Derewenda & Vekilov, 2006).
The properties of the PGAs and their easy accessibility
make them, in our opinion, exciting and new crystallization
polymers. We therefore would like to bring them to the
attention of the crystallization community at this initial stage
of exploration in order to encourage their future validation
and trials in other laboratories.
All PGAs described here were tested for cryoprotection
capabilities at a wide range of concentrations, but they did not
radically help crystal vitriﬁcation. They are not obvious
cryoprotectants as are 200–6K molecular-weight PEGs at
higher  25–40%(w/v) concentrations. However, this part of
the research is still under exploration.
In summary, we report here the development and testing of
a new type of macromolecular precipitant based on poly-
-glutamic acid. Despite large molecular weights ranging from
 200 kDa to over 1000 kDa and intrinsic heterogeneity of the
molecular-weight distribution, these PGAs showed very
encouraging effectiveness in the crystallization process as
additives or stand-alone precipitants. The screens presented
here, including the ‘ﬁnal’ PGA screen, represent only preli-
minary exploration of PGAs rather than ultimate PGA-based
crystallization protocols. This very application-driven report
highlights the need for further investigations on the effects of
PGAs on protein structure and function. It is possible that
they have other applications as protein stabilisers, folding
facilitators (macromolecular chaperone effects), simulators of
protein cellular matrix etc. There is still great and unexplored
potential in crystallization chemistry that merits urgent
attention to facilitate the further progress of structural
biology.
We are very grateful to members of the YSBL and
Department of Biology, University of York (especially Elena
Blagova, Mark Fogg and Nick Housden) for testing the PGA
screens on their ongoing projects. This research was supported
by Wellcome Trust grant 072827/Z/03/Z on which JK and TCH
were also employed.
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